Federal Hearings on Anti-Psychotic Meds for Elders

posted Dec 13, 2011, 11:42 AM by Frank Baskin   [ updated Dec 13, 2011, 11:45 AM ]

The Senate Special Committee on Aging  convened a hearing entitled "Overprescribed: The Human and Taxpayers' Costs of Antipsychotics in Nursing Homes."  The hearing examined the increased...FOR MORE CLICK TITLE... prescribing of antipsychotic medications in the nursing home setting among residents with dementia, despite a Food and Drug Administration "black box" warning. 


Increased dementia training and education for all members of the interdisciplinary team and nursing home surveyors was a common theme among all who testified at the hearing which included Daniel R. Levinson, Inspector General; Dr. Patrick Conway, Director and Chief Medical Officer, Centers for Medicare and Medicaid Services; Tom Hlavacek, Executive Director, Alzheimer's Association of Southeast Wisconsin; Toby Edelman, Senior Policy Attorney, Center for Medicare Advocacy; and Cheryl Phillips, MD, Senior Vice President of Advocacy, LeadingAge, and Dr. Jonathan Evans, Vice President, American Medical Directors Association.


The hearing focused on a recent Inspector General report on this issue. The Centers for Medicare and Medicaid( CMS) is considering regulations on the use of these drugs for nursing home residents.